STOCK TITAN

DataMeds AI, Inc. (Nasdaq: MEDS) sets Aug. 7 record date for 50 DREAM coins per share

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

DataMeds AI, Inc. updated the record date for its planned distribution of the Dream Bowl 2026 Meme Coin to stockholders to August 7, 2026. Holders of common stock on that date are entitled to receive 50 DREAM coins per share, compared with the previously announced distribution of one coin per share.

The distribution date will be set later in coordination with DataVault AI. As of this announcement, the company has 2,847,198 common shares outstanding; about 1,533,930 shares are subject to 90‑day lock-up agreements, while 919,465 shares are held at DTCC and available for trading. DataMeds also reports 80,826 outstanding cash warrants with a $35.00 exercise price and no currently convertible debt or preferred equity.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Meme coins per share 50 Dream Bowl 2026 Meme Coins per share Distribution to holders of common stock as of August 7, 2026 record date
Record date August 7, 2026 Record date for determining stockholders entitled to receive Dream Bowl 2026 Meme Coins
Shares outstanding 2,847,198 shares Common shares outstanding as of the press release date
Shares under lock-up 1,533,930 shares Common shares subject to 90-day lock-up agreements from July 27, 2026
DTCC trading float 919,465 shares DataMeds common shares deposited in DTCC and available for trading
Cash warrants outstanding 80,826 warrants Warrants eligible to be exercised into free-trading common shares
Warrant exercise price $35.00 per share Fixed exercise price of outstanding cash warrants
record date financial
"announced an updated record date for the distribution of the Dream Bowl"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
lock-up agreements financial
"Certain stockholders holding approximately 1,533,930 common shares... have entered into lock-up agreements"
A lock-up agreement is a contract that prevents company insiders—founders, employees, and early investors—from selling their shares for a set period after a public stock offering. It matters to investors because it keeps a large block of shares off the market temporarily; when the lock-up ends, those holders can sell and this increased supply can cause the stock price to fall, similar to a timed release that suddenly opens a valve.
Depository Trust & Clearing Corporation (DTCC) financial
"There are currently 919,465 DataMEDS common shares deposited in Depository Trust & Clearing Corporation (DTCC)"
cash warrants financial
"There is a total of 80,826 cash warrants outstanding, each with a fixed exercise price"
Cash warrants are tradable rights that let an owner benefit from a stock’s price movement by exchanging the warrant for a cash payment equal to the difference between the market price and a set exercise price, rather than receiving actual shares. For investors they offer leveraged exposure to a stock’s gain or loss with no direct ownership, and they matter because they change potential payoffs and a company’s cash obligations without diluting share count.
Nasdaq listing standards regulatory
"the Company’s ability to maintain compliance with Nasdaq listing standards"
Nasdaq listing standards are the set of rules a company must meet to be admitted to and remain on the Nasdaq stock market, covering financial thresholds (like minimum share price and earnings), reporting and disclosure, and board and governance practices. They matter to investors because meeting these standards signals a baseline of financial health and transparency, reduces the risk of sudden delisting, and helps ensure a market with enough buyers and sellers—like a safety checklist that keeps the trading venue orderly and trustworthy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What change did DataMeds AI (MEDS) make to the Dream Bowl 2026 Meme Coin distribution?

DataMeds AI updated the record date to August 7, 2026 and set a distribution of 50 DREAM coins per share of common stock. This replaces the previously announced structure of one coin per share tied to an earlier record date.

How many Dream Bowl 2026 Meme Coins will DataMeds AI (MEDS) stockholders receive?

Stockholders of DataMeds AI will be entitled to 50 Dream Bowl 2026 Meme Coins for each share of common stock held on August 7, 2026. Eligibility is based solely on holdings as of that record date; the actual distribution date will be set later.

What is DataMeds AI’s (MEDS) current share count and trading float?

DataMeds AI reports 2,847,198 common shares outstanding. Approximately 1,533,930 shares are under 90-day lock-up agreements, while 919,465 shares are deposited at DTCC and currently available for trading in the market.

Are there convertible securities that could add to DataMeds AI (MEDS) free-trading share count?

The company states it has no debt or preferred equity securities currently eligible to convert into free-trading common shares. It does have 80,826 cash warrants outstanding, each exercisable into common stock at a $35.00 per-share exercise price.

When will DataMeds AI (MEDS) actually distribute the Dream Bowl 2026 Meme Coins?

The company has not set a specific distribution date yet. It explains that the distribution date will be determined by a subsequent resolution in coordination with DataVault AI, Inc., after which eligible stockholders can receive their DREAM coins.

How will DataMeds AI (MEDS) collect wallet information for the Dream Bowl 2026 Meme Coin distribution?

DataMeds AI plans to distribute notices and forms to stockholders, or coordinate this through its transfer agent, to obtain each holder’s digital wallet information. This will enable eligible investors to receive their Dream Bowl 2026 Meme Coins once distributed.
false 0002030763 0002030763 2026-07-27 2026-07-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 27, 2026

 

DATAMEDS AI, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-42530   93-3264234

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

3000 Bayport Drive

Suite 950

Tampa, FL 33607

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (844) 203-6092

 

Wellgistics Health, Inc.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   MEDS   The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

On July 27, 2026, DataMeds AI, Inc. issued a press release announcing that the record date for the distribution of the Dream Bowl 2026 Meme Coin has been updated to August 7, 2026.

 

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description of Exhibit
99.1   Press release dated July 27, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 28, 2026 DATAMEDS AI, INC.
     
  By: /s/ Prashant Patel
    Prashant Patel, President

 

 

 

Exhibit 99.1

 

DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders

 

AMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, “DataMEDS,” or the “Company”), a health information technology leader implementing EinsteinRx artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain to optimize the prescription medicines reimbursement and dispensing journey, today announced an updated record date for the distribution of the Dream Bowl 2026 Meme Coin (https://www.biconomy.com/exchange/DREAM1_USDT) to DataMEDS stockholders. On December 3, 2025, DataMEDS announced that it would distribute one (1) Dream Bowl 2026 Meme Coin for every one (1) share of DataMEDS Health common stock held as of a designated record date. On July 20, 2026, DataMEDS previously set a new record date of July 31, 2026 for determining stockholders entitled to receive the Dream Bowl 2026 Meme Coin. Today, the Company further updated the record date to August 7, 2026.

 

Holders of DataMEDS common stock as of the new record date of August 7,2026 will be entitled to receive fifty (50) Dream Bowl 2026 Meme Coins for each share of DataMEDS common stock that they hold. DataMEDS will distribute (or coordinate with DataMEDS’s transfer agent to distribute) any necessary notices and forms to stockholders to obtain each holder’s digital wallet information to allow such holders to receive their Dream Bowl 2026 Meme Coins. The distribution date (the “Distribution Date”) will be determined by subsequent resolution in coordination with DataVault AI, Inc. (NASDAQ:DVLT).

 

As of the date of this press release, DataMEDS has 2,847,198 common shares outstanding. Certain stockholders holding approximately 1,533,930 common shares, representing a majority of the outstanding common shares, have entered into lock-up agreements that preclude the sale of their shares into the market for at least ninety (90) days from today’s date. There are currently 919,465 DataMEDS common shares deposited in Depository Trust & Clearing Corporation (DTCC) available for trading. There are no debt or preferred equity securities of the Company that are eligible to convert into free trading common shares at the current time. There is a total of 80,826 cash warrants outstanding, each with a fixed exercise price of $35.00 per share, that are currently eligible to be exercised into free trading common shares. Investors should refer to the Company’s filings with the Securities and Exchange Commission for additional information regarding the Company’s capitalization and outstanding securities.

 

About DataMeds AI, Inc.

 

DataMeds AI, Inc. (formerly Wellgistics Health) is a leading Health IT company that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units to deliver a better healthcare experience for consumers. Headquartered in Tampa, Fla., DataMeds AI incorporates the artificial intelligence platform EinsteinRx and blockchain-enabled smart contacts platform PharmacyChaininto the Health Lives Here Mobile application and Tollo Health.

 

 

 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the proposed corporate name change to DataMeds AI, Inc.; the proposed rebranding of the Company’s Pharmacy and Pharmacy Services division as Corexa Health; the Company’s proposed transaction with DataVault AI Inc., Scilex Holding Company, EOS Holdings and HealthBridge Advisors; the anticipated timing, structure, terms and completion of such transaction; the satisfaction or waiver of closing conditions; the receipt of stockholder approval and any other required approvals; the Company’s anticipated business strategy, operating plans and growth opportunities; the integration of telemedicine, pharmacy, laboratory, wearable-device, artificial intelligence, blockchain and data-management technologies; the proposed development, commercialization and expansion of EinsteinRx AI, PharmacyChain, Health Lives Here and related platforms; the Company’s ability to empower patients to access, manage, control or monetize health data; the anticipated benefits of the Company’s technology platforms, strategic relationships and business combinations; the Company’s capitalization, outstanding securities, lock-up arrangements, public float and registration statements; the Company’s ability to maintain compliance with Nasdaq listing standards; and the Company’s liquidity, capital resources and ability to fund operations.

 

Forward-looking statements are based on current expectations, estimates, projections and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, the risk that the proposed name change may not be approved by stockholders or otherwise completed; the risk that the proposed transaction may not be completed on the anticipated terms or timeline, or at all; the risk that closing conditions may not be satisfied or waived; risks related to integrating multiple businesses, technologies and platforms; risks related to the development, commercialization, adoption, scalability and regulatory treatment of artificial intelligence, blockchain-enabled data management, telemedicine, pharmacy, laboratory, wearable-device and digital health technologies; risks related to healthcare privacy, cybersecurity, data ownership, data monetization and compliance with applicable healthcare, pharmacy, consumer protection, data protection and securities laws; risks related to the Company’s liquidity, capital resources, indebtedness, dilution, outstanding securities, registration statements and ability to raise additional capital; risks related to maintaining compliance with Nasdaq listing standards; market, regulatory, competitive and operational risks affecting the healthcare, pharmacy, pharmaceutical distribution, artificial intelligence, technology and digital asset sectors; and other risks described in the Company’s filings with the Securities and Exchange Commission.

 

Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

DataMEDS AI Media Contact

 

James Lambert, Vice President
Rubenstein Public Relations
Phone: 212.805.3024
Email: jlambert@rubensteinpr.com

 

DataMEDS AI Investor Contact

 

Investor Relations: IR@wellgisticshealth.com

 

 

Filing Exhibits & Attachments

4 documents